Versant Venture Capital IV, L.P.
CIK 0001456590
10% Owner
Filings
5
Latest Aug 12, 2024
Issuers covered
3
Showing
5 of 5
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | -19.9% | -19.9% | +4.5% | -44.2% |
| 90 days | 2 | 50% | +3.7% | +3.7% | +22.4% | -14.9% |
| 180 days | 2 | 100% | +19.4% | +19.4% | +30.7% | +8.2% |
| 365 days | 2 | 100% | +43.5% | +43.5% | +57.7% | +29.2% |
Issuers
Companies where Versant Venture Capital IV, L.P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| OYST | Oyster Point Pharma, Inc. | 2 | Jan 4, 2023 |
| TPST | Tempest Therapeutics, Inc. | 2 | Aug 12, 2024 |
| CTNM | Contineum Therapeutics, Inc. | 1 | Apr 11, 2024 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|